Breaking News, Collaborations & Alliances

FUJIFILM Diosynth Biotechnologies to Manufacture TG Therapeutics’ MS Drug

Signs a manufacturing supply agreement with TG Therapeutics for BRIUMVI.

Author Image

By: Charlie Sternberg

Associate Editor

FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO), has announced a multi-year manufacturing supply agreement with TG Therapeutics Inc. for BRIUMVI, a therapy for relapsing forms of multiple sclerosis (RMS).   Under the terms of the agreement, FUJIFILM Diosynth Biotechnologies will provide secondary manufacturing supply for BRIUMVI at its new biopharmaceutical manufacturing facility in Holly Springs, North Carolina. The facility is expected ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters